This inventor holds 3 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Smilebiotek Zhuhai Limited. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zhuhai, CN (2023)
- Guangdong, CN (2024)
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Lai Wei in Intraocular Disease Treatment
Introduction
Lai Wei is a notable inventor based in Zhuhai, China, recognized for his contributions to the field of ophthalmology. He holds three patents that focus on methods and compositions for assessing and treating intraocular diseases and disorders. His work aims to improve the quality of life for individuals suffering from various eye conditions.
Latest Patents
Lai Wei's latest patents include innovative methods and compositions for assessing and treating intraocular diseases. One of his significant patents involves compositions, devices, and systems designed to assess, treat, and prevent intraocular diseases caused by microbial infections. Another patent focuses on age-related macular degeneration (AMD), providing methods for treatment and prevention in human patients. Additionally, he has developed screening methods and animal models related to intraocular diseases, which are essential for identifying candidate therapeutics for conditions like AMD.
Career Highlights
Lai Wei is currently associated with Smilebiotek Zhuhai Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating serious eye diseases, making him a key figure in the field of ocular health.
Collaborations
Lai Wei collaborates with talented individuals such as Yan Zhang and Hui Ouyang, who contribute to his innovative projects and research initiatives.
Conclusion
Lai Wei's innovative work in the treatment of intraocular diseases showcases his commitment to advancing medical science. His patents reflect a significant contribution to ophthalmology, with the potential to improve patient outcomes in eye health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile